NDC 65757-500 – Aristada Initio
Aripiprazole Lauroxil 675 mg/2.4mL · Injection, Suspension, Extended Release · Intramuscular
Product NDC65757-500
Product details
- Brand name
- Aristada Initio
- Generic name
- Aripiprazole lauroxil
- Labeler
- Alkermes, Inc.
- Dosage form
- Injection, Suspension, Extended Release
- Route
- Intramuscular
- Marketing category
- NDA · NDA209830
- Marketed since
- June 29, 2018
- Listing expires
- December 31, 2026
- Pharmacologic class
- Atypical Antipsychotic
Active ingredients
- Aripiprazole Lauroxil 675 mg/2.4mL
Uses, dosage, side effects and warnings for Aristada Initio →
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 65757-500-03 | 1 SYRINGE in 1 CARTON (65757-500-03) / 2.4 mL in 1 SYRINGE | Jun 29, 2018 |
| 65757-500-04 sample | 1 SYRINGE in 1 CARTON (65757-500-04) / 2.4 mL in 1 SYRINGE | Jun 29, 2018 |